ADPKD (Autosomal DominantPolycystic
INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common monogenic diseases, and is inherited in a dominant fashion. The disease is characterized by the development of large, fluid-filled renal cysts and ultimately leads to kidney failure (1) . ADPKD is caused by mutations in at least the PKD1 and PKD2 genes. Polycystin2 (PKD2) is a large, membrane-associated protein with putative roles in signal transduction and Ca 2＋ regulation (2) (3) (4) . There are three types of PKD2 and PKD1 mutations that lead to cyst formation: gain of function, loss of function, and LOH (loss of heterozygosity) (5) (6) (7) (8) (9) (10) .
c-Myc is known to be involved in cell proliferation, apoptosis, differentiation, and neoplasia, and Myc plays an important role in apoptosis and proliferation, the latter of which is important during renal cyst formation (11, 12) . According to a recent report, c-Myc is downstream of PKD1 (5), but the roles of PKD2 and c-Myc in cyst formation remain unclear. In the present study, to investigate the involvements of PKD2 and c-Myc in cyst formation, we analyzed the gene expression patterns in PKD2 and c-Myc overexpressing cells, and identified the molecular targets of PKD2 and c-Myc during cyst formation. Our findings indicate that NCAM plays an important role during cyst formation by PKD2 overexpression.
RESULTS AND DISCUSSION
Gene expression patterns in PKD2 and in PKD2/c-Myc overexpressing cells ADPKD occurs in 1 person per 1000, primarily as a result of a mutation in either the PKD1 or PKD2 genes (1, (13) (14) (15) . Moreover, it has been shown that proto-oncogenes including c-Myc, c-Fos, c-ha-Ras are overexpressed in human ADPKD and in a mouse model of ADPKD (16) . However, the relationships between causative genes and related genes remain unclear. To identify genes transcriptionally regulated by PKD2 or c-Myc, we established a PKD2 overexpressing cell line overexpression of PKD2 in these cells immunocytochemically (Fig. 1B) . We then transiently induced the c-Myc gene in these cells, and confirmed the overexpressions of PKD2 and c-Myc in these cells by semi-quantitative RT-PCR (Fig. 1A) . To analyze gene expression profiles in PKD2 and c-Myc overexpressing cells, we used a human cDNA microarray containing 8,209 human genes. Clustering analysis (data not shown) identified 9 genes that showed a minimum 2-fold change in expression ( Table 1 ). The majority of the genes identified were found to participate in adhesion, metabolism, the cell cycle, signal transduction, and transport.
Validation of microarray data
To corroborate the cDNA microarray data, semiquantitative RT-PCR analysis was performed on eight selected genes found to be differentially expressed in PKD2 or PKD2/c-Myc overexpressing cells (Fig. 2) . These genes included NCAM, WNT10B, EGR1, ENO2, AMFR, LTBP1, p27, CDK2. In general, RT-PCR data concurred with cDNA microarray data, and showed that the expressions of NCAM and WNT10B were significantly lower in PKD2 overexpressing cells, and that the expressions of CDK2 and p27 were significantly higher in PKD2/ c-Myc overexpressing cells.
NCAM expression in vitro and in vivo
We verified expression changes in NCAM at the protein level by western blotting. NCAM expression was reduced in PKD2 overexpressing cells (Fig. 3A) . Fig. 3B shows densitometric NCAM/actin ratio results. Moreover, NCAM expression changes at the transcriptional level were found to coincide with changes at the protein level. and cystogenesis induced by PKD2, we confirmed NCAM expression in PKD2 transgenic mouse kidneys (the PKD2 overexpressing mouse model is an established animal model of ADPKD). Recently, we generated and analyzed renal cyst formation in the PKD2 overexpressing mouse model. In particular, in this model, c-myc expression was found to be unchanged (data not shown). As shown in Fig. 3C , NCAM expression was found to be significantly lower in PKD2 transgenic mouse kidneys compared with controls. To investigate NCAM expression in kidney tubules, we adopted an immunohistochemical approach. As shown in Fig. 3D , tubule numbers in PKD2 transgenic mice were lower than in wildtype mice, and NCAM expression was significantly lower in tubules in PKD2 transgenic mouse kidneys compared with controls (Fig. 3D) . NCAM is a member of the immunoglobulin superfamily of proteins that mediate homophilic (NCAM-NCAM) and heterophilic cell-cell interactions (17, 18) . Moreover, the presence of NCAM appears to guide the sequential differentiation and polarization of normal renal epithelium, and reductions in the level of NCAM lead to the perpetuation of defective renal tubule epithelial cell polarization, which contributes to cyst formation (19) .
In our data NCAM expression was significantly reduced when PKD2 was overexpressed, which suggests that NCAM acts downstream of PKD2 overexpression and that it plays an important role in cyst formation induced by PKD2 overexpression. Summarizing, we identified several genes, including NCAM and CDK2, which are regulated by PKD2 or c-Myc, and of these genes NCAM was found to be the most important marker gene of cyst formation induced by PKD2 overexpression. http://bmbreports.org BMB reports 
MATERIALS AND METHODS

Cell culture, plasmid constructions, and transfection
HEK 293 cells were cultured and maintained in DMEM (GIBCO/ BRL) supplemented with 10% FBS (GIBCO/BRL), 100 U/ml penicillin, and 100 ug/ml streptomycin at 37 o C in 5% CO2. The PKD2 expression plasmid used was constructed by subcloning PKD2 full-length cDNA into zeocin-resistant plasmid pcDNA3.1 vector. An expression vector for c-myc was constructed by subcloning PCR-amplified cDNA into the zeocin-resistant plasmid pcDNA3.1 vector. HEK 293 cells were plated in 30 mm dishes, transfected with 4 μg of linearized pcDNA3.1-PKD2 using Lipofectamine 2000 (Invitrogen), and then digested with PvuI. Stable transfectants were selected in media containing 400 μg/ml zeocin (Invitrogen). PKD2 stably expressing cells were transiently transfected with pcDNA3.1-c-myc using Lipofectamine 2000 (Invitrogen).
Immunocytochemistry
The cells were fixed in MeOH:Acetone (1:1) fixation solution, washed with PBS (2 × 5 min) then blocked for 30 min with a blocking solution (PBS containing 10% fetal bovine serum). Fixed cells were incubated with goat anti-PKD2 (Santacruz, 1:500) overnight at 4 o C. After washing slides in PBS three times, cells were incubated for 30 min with secondary antibody (Upstate Biotechnology), and positive cells were detected using a DAB reaction kit. Slides were counterstained with hematoxylin.
cDNA microarray analysis
Total RNA from cells was extracted using TRIZOL reagent (Invitrogen), according to the manufacturer's instructions. We used a house human cDNA microarray harboring 8,208 unique human cDNAs including 296 positive controls, GAPDH, and β-actin. Cy3 and Cy5 labeled cDNA probes were synthesized and hybridized using a 3DNA Array 50 Expression array detection kit (Genisphere), according to the manufacturer's instructions. Hybridized microarrays were washed with 1X SSC/0.1% SDS at 65 o C for 10 min, and then with 0.2X SSC at room temperature (2 × 10 min). Washed microarrays were immediately dried by centrifugation.
Data acquisition and analysis
Hybridization slides were scanned using an ArrayWoRx scanner (Applied Precision Inc.) and acquired images were analyzed with ImaGene (Biodiscovery Inc.) using default settings and auto image segmentation. All data normalization and statistical analysis were performed using GeneSight (Biodiscovery Inc). For clustering analysis normalized data was analyzed using K-means clustering methods.
Semi-quantitative RT-PCR analysis
Total RNA from cells was isolated using TRIZOL (Invitrogen), according to the manufacturer's instructions. 5 μg of total RNA was reverse transcribed by using superscript II reverse transcriptase (Invitrogen). The generated cDNA was PCR amplified using primers specific for PKD2, c-myc, GAPDH, NCAM, CDK2, JNK2, p27, Wnt10b, EGR1, ENO1, AMFR, and LTBP 1.
Western blot analysis
Proteins from whole cells lysates and tissues were obtained using ice-cold RIPA buffer (ELPIS Biotechnology). After 20 min incubation on ice, lysates were cleared by microcentrifugation http://bmbreports.org (13,000 rpm for 15 min at 4 o C). Proteins were quantified using the BCA protein assay. Western blot analysis was performed using anti-NCAM (Abcam), anti-β-actin (Sigma), and anti-PC2 (Santacruz). Immobilized antibodies were detected by chemiluminescence using ECL plus kits (Amersham bioscience)
Immunohistochemistry
Immunohistochemistry was performed using paraffin sections (10 μm). Endogenous peroxidase was blocked with 3% hydrogen peroxide (LAB Vision) for 10 min, and biotin was blocked using CAS blocking solution (Zymed) for 1 h at room temperature. Slides were then incubated with the primary antibody overnight at 4 o C using anti-NCAM (Santacruz). After washing, slides were incubated with secondary antibody (DAKO, CA, USA) for 30 min at RT, and then incubated with streptavidin-HRP (DAKO) for 30 min at room temperature. After washing, slides were reacted with AEC (Zymed). Sections were counterstained with Hematoxylin.
